Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$4.40
-7.2%
$5.67
$2.90
$11.16
$356.87M0.473.37 million shs9.29 million shs
American Tower Corporation stock logo
AMT
American Tower
$221.13
-0.3%
$216.55
$172.51
$243.56
$103.52B0.822.50 million shs1.46 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
+3.49%-3.27%-20.34%+13.94%-31.30%
American Tower Corporation stock logo
AMT
American Tower
+0.44%-0.57%+4.14%+6.27%+13.09%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
2.325 of 5 stars
3.41.00.00.03.11.70.6
American Tower Corporation stock logo
AMT
American Tower
3.9985 of 5 stars
2.63.01.73.14.21.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.75
Moderate Buy$18.20313.17% Upside
American Tower Corporation stock logo
AMT
American Tower
3.11
Buy$240.888.80% Upside

Current Analyst Ratings Breakdown

Latest AMT, 4DX, ADR, ALT, and ADO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/10/2025
Altimmune, Inc. stock logo
ALT
Altimmune
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSell
7/10/2025
Altimmune, Inc. stock logo
ALT
Altimmune
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$25.00 ➝ $15.00
7/8/2025
American Tower Corporation stock logo
AMT
American Tower
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$250.00 ➝ $260.00
6/27/2025
Altimmune, Inc. stock logo
ALT
Altimmune
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
6/27/2025
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
5/19/2025
American Tower Corporation stock logo
AMT
American Tower
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$255.00
5/1/2025
American Tower Corporation stock logo
AMT
American Tower
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$240.00 ➝ $250.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$230.00 ➝ $240.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$234.00 ➝ $248.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$248.00 ➝ $260.00
4/30/2025
American Tower Corporation stock logo
AMT
American Tower
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetStrong-Buy ➝ Strong-Buy$231.00 ➝ $251.00
(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$20K17,863.82N/AN/A$1.74 per share2.53
American Tower Corporation stock logo
AMT
American Tower
$10.18B10.18$11.62 per share19.06$20.64 per share10.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$95.06M-$1.26N/AN/AN/A-451,200.00%-65.44%-58.43%8/6/2025 (Estimated)
American Tower Corporation stock logo
AMT
American Tower
$2.26B$3.8956.9722.141.6417.34%30.20%4.82%7/29/2025 (Estimated)

Latest AMT, 4DX, ADR, ALT, and ADO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.3006N/AN/AN/AN/AN/A
7/29/2025Q2 2025
American Tower Corporation stock logo
AMT
American Tower
$2.59N/AN/AN/A$2.58 billionN/A
5/13/2025Q1 2025
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.26+$0.09-$0.26$0.00 million$0.01 million
4/29/2025Q1 2025
American Tower Corporation stock logo
AMT
American Tower
$2.41$2.75+$0.34$2.75$2.54 billion$2.56 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
American Tower Corporation stock logo
AMT
American Tower
$6.803.07%N/A174.81%1 Years

Latest AMT, 4DX, ADR, ALT, and ADO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2025
American Tower Corporation stock logo
AMT
American Tower
quarterly$1.703.21%6/13/20256/13/20257/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
15.85
15.85
American Tower Corporation stock logo
AMT
American Tower
3.43
0.81
0.81

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
American Tower Corporation stock logo
AMT
American Tower
92.69%

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
4.10%
American Tower Corporation stock logo
AMT
American Tower
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5081.11 million77.78 millionOptionable
American Tower Corporation stock logo
AMT
American Tower
4,691468.14 million467.34 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Altimmune stock logo

Altimmune NASDAQ:ALT

$4.40 -0.34 (-7.17%)
Closing price 04:00 PM Eastern
Extended Trading
$4.38 -0.02 (-0.45%)
As of 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

American Tower stock logo

American Tower NYSE:AMT

$221.13 -0.70 (-0.32%)
Closing price 03:59 PM Eastern
Extended Trading
$221.01 -0.12 (-0.05%)
As of 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.